Assessing Patient Comfort, Anxiety, and Satisfaction During CR Comparing Conventional Drops With ROC

The study will involve participants aged 3-16 years, with no significant refractive error or ocular pathologies. Patients will be randomly assigned to receive either cyclopentolate or tropicamide with phenylephrine. The primary outcomes include patient comfort, anxiety levels, satisfaction, and procedure time. Discomfort and anxiety will be measured using questionnaires such as the Visual Analog Scale for Comfort and the State-Trait Anxiety Inventory. The study will help determine if rapid-onset cycloplegic provide a better patient experience by reducing discomfort and anxiety. By evaluating these factors, the research seeks to improve clinical practices in optometry and ophthalmology, particularly in pediatric eye examinations.

Inclusion criteria

• Patients aged 10-20years.
• Both Male and Female
• Healthy participants with no abnormalities detected in anterior segment structures or fundus examination using slit-lamp biomicroscopy and a 90-diopter lens.
• No significant refractive error (within the range of ±1 diopter in spherical equivalent).

Exclusion criteria

• History of severe allergic reactions or adverse effects to cycloplegic agents
• Severe anxiety, panic disorders, or other psychological conditions that may interfere with reporting the experience accurately.
• Uncontrolled systemic diseases (e.g., uncontrolled diabetes or cardiovascular conditions) that may impact the response to cycloplegic agents.
• Recent ocular surgery (e.g., LASIK, cataract surgery) or eye trauma affecting refraction accuracy or comfort.
• Presence or history of any intraocular diseases, including glaucoma, uveitis, and retinal disorders.
• Systemic disorders such as hypertension, cardiovascular disease, or respiratory disease.